Q1 2026 Holdings
Filed 2026-05-15 | 8 holdings | $237.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N.V.(PHVS) | COM | N69605108 | $135.0M | 4,778,581 | 56.9% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $33.2M | 503,295 | 14.0% |
| Eikon Therapeutics, Inc.(EIKN) | COM | 282564103 | $20.6M | 1,943,682 | 8.7% |
| Lyell Immunopharma, Inc.(LYEL) | COM | 55083R203 | $16.1M | 800,399 | 6.8% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $10.0M | 1,000,000 | 4.2% |
| Xenon Pharmaceuticals Inc.(XENE) | COM | 98420N105 | $9.3M | 160,000 | 3.9% |
| Alector, Inc.(ALEC) | COM | 014442107 | $8.4M | 3,887,200 | 3.5% |
| Maze Therapeutics, Inc.(MAZE) | COM | 578784100 | $4.7M | 156,901 | 2.0% |